DDI Study of Orelabrutinib
Clinical trial NCT05316857 · COMPLETED
Trial details
- NCT number
- NCT05316857
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-16
- Primary completion
- 2022-01-04
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.